Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LPA”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Not applicableNot Yet RecruitingNCT07184034
What this trial is testing

Lipoprotein a Assessment and Relation to Ca Score in CAD Patients Using MSCT

Who this might be right for
Coronary Artery Disease (CAD)
Assiut University 150
Testing effectiveness (Phase 2)Study completedNCT02160899
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a)

Who this might be right for
Elevated Lipoprotein(a)
Ionis Pharmaceuticals, Inc. 64
Large-scale testing (Phase 3)Study completedNCT02729025
What this trial is testing

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia
Amgen 129
Testing effectiveness (Phase 2)Looking for participantsNCT05646381
What this trial is testing

Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Who this might be right for
Aortic Stenosis
Novartis Pharmaceuticals 502
Not applicableNot Yet RecruitingNCT07382414
What this trial is testing

Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial

Who this might be right for
Coronary Artery DiseaseHypercholesterolemiaLipoprotein(a)+1 more
Tor Biering-Sørensen 100,000
Not applicableStudy completedNCT06626659
What this trial is testing

Lipoprotein (a) and Vascular Regenerative Cell Content

Who this might be right for
Cardiovascular DiseasesAtherosclerosis Cardiovascular DiseaseIschemic Heart Disease+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 40
Not applicableStudy completedNCT03172611
What this trial is testing

A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles

Who this might be right for
Hypercholesterolemia
Texas Woman's University 33
Not applicableUnknownNCT05496790
What this trial is testing

Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - (RELACS) Study

Who this might be right for
Acute Coronary SyndromeLipoprotein DisorderAcute Myocardial Infarction+1 more
University of Campania Luigi Vanvitelli 1,000
Not applicableEnrolling By InvitationNCT07177612
What this trial is testing

Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).

Who this might be right for
Lipoprotein(a)Lipoprotein(a), Hyper-Lp(a)-Emia
Changi General Hospital 20,000
Large-scale testing (Phase 3)Enrolling By InvitationNCT06406140
What this trial is testing

Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis Patients

Who this might be right for
End-stage Renal Disease
Al-Azhar University 50
Testing effectiveness (Phase 2)Study completedNCT05565742
What this trial is testing

LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 320
Large-scale testing (Phase 3)Active Not RecruitingNCT05900141
What this trial is testing

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Who this might be right for
Hyperlipoproteinemia (a)
Novartis Pharmaceuticals 41
Early research (Phase 1)Study completedNCT03626662
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)

Who this might be right for
Cardiovascular Disease
Amgen 79
Not applicableLooking for participantsNCT05962827
What this trial is testing

Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY

Who this might be right for
Lymphedema
Centre Hospitalier Universitaire de Nice 100
Post-approval studies (Phase 4)UnknownNCT00433823
What this trial is testing

A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis

Who this might be right for
Coronary Heart DiseaseDiabetes MellitusNon-Coronary Atherosclerotic Disease+1 more
Abant Izzet Baysal University
Testing effectiveness (Phase 2)Active Not RecruitingNCT07185776
What this trial is testing

HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Fujian Shengdi Pharmaceutical Co., Ltd. 203
Not applicableStudy completedNCT03887520
What this trial is testing

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 49,001
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Load More Results